NCT06173310
- Conditions
- Borderline-resectable Pancreatic Cancer
- Locations
-
- Indiana University Medical Center Indianapolis, Indiana, United States
- The Ohio State University Columbus, Ohio, United States
Clinical trial condition
Explore clinical trials studying Borderline-resectable Pancreatic Cancer. Study availability and eligibility vary by location and protocol.
NCT06173310